Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 11, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 37
- −1 vs. Q1 2023
- Portfolio value
- $289.1M
- +$27.3M (+10.4%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| APLSApellis Pharmaceuticals, Inc. | COM | 241,690 | $22.0M | 7.6% | −42,000−14.8% | Reduced | History |
| PRTAProthena Corp Public Ltd Co | SHS | 317,300 | $21.7M | 7.5% | −14,300−4.3% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 846,953 | $20.3M | 7.0% | −69,400−7.6% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 357,765 | $16.8M | 5.8% | −31,100−8.0% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 1,325,775 | $16.7M | 5.8% | −134,400−9.2% | Reduced | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 406,859 | $16.5M | 5.7% | −37,800−8.5% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 287,556 | $16.5M | 5.7% | +287,556 | New | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 608,628 | $16.0M | 5.5% | −5,603−0.9% | Reduced | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 492,545 | $15.7M | 5.4% | −46,900−8.7% | Reduced | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 302,000 | $15.4M | 5.3% | +302,000 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 797,527 | $14.4M | 5.0% | −70,900−8.2% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 125,457 | $14.4M | 5.0% | +2,700+2.2% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 139,772 | $12.5M | 4.3% | −16,300−10.4% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 369,093 | $12.0M | 4.2% | −44,700−10.8% | Reduced | History |
| CLVTClarivate PLC | ORD SHS | 1,247,406 | $11.9M | 4.1% | +1,247,406 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 761,721 | $11.7M | 4.0% | −113,500−13.0% | Reduced | History |
| ARVNArvinas, Inc. | COM | 411,500 | $10.2M | 3.5% | −80,800−16.4% | Reduced | History |
| BHCBausch Health Companies Inc. | Stock | 1,165,000 | $9.32M | 3.2% | +1,165,000 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 701,570 | $8.81M | 3.0% | −144,700−17.1% | Reduced | History |
| SLDBSolid Biosciences Inc. | COM NEW | 961,251 | $5.04M | 1.7% | +472,394+96.6% | Added | History |
| Ares Acquisition CorporationG33032122 | *W EXP 99/99/999 | 504,706 | $403.8K | 0.1% | 00.0% | Unchanged | – |
| Bridgetown Holdings LtdG1355U121 | *W EXP 09/30/202 | 895,000 | $222.0K | 0.1% | 00.0% | Unchanged | – |
| Churchill Capital Corp V17144T115 | *W EXP 10/29/202 | 612,000 | $110.2K | <0.1% | 00.0% | Unchanged | – |
| Churchill Capital Corp VI17143W119 | *W EXP 02/17/202 | 540,000 | $97.2K | <0.1% | 00.0% | Unchanged | – |
| CLDWWCalidi Biotherapeutics, Inc. | *W EXP 03/14/202 | 655,200 | $85.2K | <0.1% | 00.0% | Unchanged | History |
| Churchill Capital Corp VII17144M110 | *W EXP 02/29/202 | 548,000 | $76.7K | <0.1% | 00.0% | Unchanged | – |
| Ross Acquisition Corp IIG7641C114 | *W EXP 02/01/202 | 439,666 | $74.4K | <0.1% | 00.0% | Unchanged | – |
| Compass Digital Acquisitn CoG2476C123 | *W EXP 09/29/202 | 459,906 | $68.4K | <0.1% | 00.0% | Unchanged | – |
| Swiftmerge Acquisition CorpG63836111 | *W EXP 12/13/202 | 490,000 | $48.0K | <0.1% | 00.0% | Unchanged | – |
| Marblegate Acquisition Corp.56608A113 | *W EXP 08/31/202 | 735,000 | $41.3K | <0.1% | 00.0% | Unchanged | – |
| Afternext Healthtech AcquisiG01109126 | *W EXP 99/99/999 | 366,666 | $31.8K | <0.1% | 00.0% | Unchanged | – |
| Conyers Park III Acqsitn Cor21289P110 | *W EXP 08/12/202 | 571,666 | $28.6K | <0.1% | 00.0% | Unchanged | – |
| Ys Biopharma Co LtdG9845F117 | *W EXP 03/15/202 | 489,999 | $23.0K | <0.1% | 00.0% | Unchanged | – |
| CNDAWConcord Acquisition Corp II | *W EXP 99/99/999 | 408,333 | $16.3K | <0.1% | 00.0% | Unchanged | History |
| Home Plate Acquisition Corp43734R111 | *W EXP 09/30/202 | 690,000 | $14.7K | <0.1% | 00.0% | Unchanged | – |
| Bilander Acquisition Corp.09001T114 | *W EXP 05/19/202 | 183,749 | $9.33K | <0.1% | 00.0% | Unchanged | – |
| Corsair Partnering CorpG2540H116 | *W EXP 07/06/202 | 334,666 | $0 | 0.0% | 00.0% | Unchanged | – |
Sold out since Q1 2023 (5)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| ISEEIVERIC bio, Inc. | COM | 723,600 | $17.6M | 6.7% | History |
| Zimmer Energy Transition Acq989570114 | *W EXP 06/16/202 | 358,270 | $60.1K | <0.1% | – |
| Jaws Hurricane Acquisitn Cor47201B111 | *W EXP 03/26/202 | 387,249 | $60.1K | <0.1% | – |
| Senior Connect Acquisitn Cor81723H116 | *W EXP 12/31/202 | 1,014,000 | $51.3K | <0.1% | – |
| Skydeck Acquisition Corp.G82220115 | *W EXP 05/13/202 | 361,756 | $18.1K | <0.1% | – |